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Stereotactic Radiosurgery for Management 
of Cavernous Malformations
Cavernous malformations (CMs) are abnormal vascular formations of the brain with an 
estimated incidence of 0.4%-0.8% in the general population.1 CMs have the potential 
to cause significant morbidity, and have been associated with epileptic seizures, intra-
cranial hemorrhage, and focal neurological deficits.2 Management options include 
non-treatment, surgical resection, and radiosurgery. We review here the efficacy of 
different management strategies for cavernous malformations and highlight the specific 
role of radiosurgery.
One of the major complications of cerebral cavernous malformations is intracranial 
hemorrhage. To optimize patient treatment, it is beneficial to be able to identify patients 
that are at an increased risk of developing a hemorrhage and would most benefit from 
intervention. The overall rate of hemorrhage in patients with CMs has been estimated 
to be 2.25%.3 The rate of hemorrhage, however, is significantly affected by the initial 
symptom presentation. Patients presenting with a hemorrhage have significantly higher 
rates of rehemorrhage compared to patients presenting due to incidental findings.3,4 
Flemming et al. found that patients presenting with hemorrhage had an overall annual 
rate of hemorrhage of 6.19% compared to patients presenting without hemorrhage of 
0.33%. With increasing use of MR imaging, the percentage of cavernous malforma-
tions found incidentally approaches 40%.1 Because the risk of hemorrhage is low in 
patients with CMs found incidentally, surgical or radiosurgery management may not 
be indicated. In contrast, patients presenting with symptoms of hemorrhage should be 
considered for therapeutic intervention due to a high risk for subsequent hemorrhage. 
One option for the management of cavernous malformations is surgical intervention by 
CM resection. There is conflicting evidence in the literature regarding the effectiveness 
of CM resection, likely due to different methodologies used for determining efficacy. 
When post-operative outcomes are compared to pre-operative values, significant 
improvement is observed as demonstrated by improvements in the modified Rankin 
scale and decreased annual hemorrhage rate.5,6 However, the results are limited by the 
fact that studies did not include a control group of patients that did not receive surgery. 
A recent retrospective study by Moultrie and colleagues compared the outcome of 
patients treated with surgical to conservative management. Patients who underwent 
CM resection had worsened short-term disability scores, increased risk of developing 
intracranial hemorrhage, and new focal neurologic deficits.7 
While these results question the utility of surgical resection for management of cavernous 
malformations, there are situations in which CM resection may be beneficial. CM resec-
tion may be indicated in patients experiencing significant symptoms secondary to a 
cavernous malformation. For example, surgical resection has been found to significantly 
decrease seizures in CM patients presenting with epileptic seizures.8,9 Similarly, patients 
with cavernous malformations in the brainstem experiencing significant symptoms 
(cranial nerve deficits, headaches, ataxia) have significant relief of their symptoms from 
minimally invasive resection, provided the CM can be accessed with minimal tissue pertu-
bation.10 Overall, it is clear that there are limitations to surgical treatment of cavernous 
malformations. Surgical resection should be reserved for easily accessible cavernous 
malformations in patients experiencing significant symptoms. For deeper-seated 
malformations, alternative treatment such 
as radiosurgery should be explored.
Stereotactic radiosurgery is an appealing 
alternative to surgical resection because 
it is minimally invasive and lacks imme-
diate morbidity.11 Radiosurgery is believed 
to induce a hyalinization and thickening 
of blood vessels resulting in luminal 
closure, or a thrombotic process in 
which shunting can no longer occur.13,14 
In contrast to surgical resection, resolu-
tion of the cavernous malformation can 
take up to two years. Radiosurgery is 
generally reserved for treating cavernous 
malformations which are in eloquent and 
difficult to reach locations considered 
high risk for microsurgery. Approximately 
20% of cerebral cavernous malformations 
are located in the brainstem region, 
demonstrating the need for minimally 
or non-invasive therapy.6 In spite of its 
appeal, conservative management is 
still recommended until the cavernous 
malformation has bled twice, or is at 
significant risk for bleeding.12 
Evidence suggests that patients with a 
high risk of hemorrhage would benefit 
most from stereotactic radiosurgery. 
Nagy et al. determined the annual hemor-
rhage rate for a single symptomatic, or 
asymptomatic bleed to be 2.4% before 
radiosurgical treatment, 5.1% in the two 
years after treatment, and 1.3% beyond 
two years. These findings suggest that 
in patients with asymptomatic CM, the 
risk of morbidity is different whether 
looking at short or long-term follow-up. 
Compared to conservative management, 
patients have a higher risk of morbidity 
the first two years after radiosurgical 
treatment. However, after two years the 
risk of morbidity is significantly decreased. 
In contrast, the risk for additional bleeds 
may be as high as 40% for patients that 
have had one previous symptomatic 
bleed.11 Radiosurgery is considered to be 
effective for high risk CM patients. Nagy 
et al. found that the rebleeding rate went 
from 30.5% before treatment to 15% in 
the first two years and further fell to 2.4% 
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Seong-Hyun Park and Chalouhi both 
suggest that radiosurgery is an alterna-
tive to microsurgery for treating patients 
with CMs in high-risk areas who are 
symptomatic and at risk for future 
bleeds.15,17 The decision for radiosurgical 
intervention in asymptomatic patients 
with incidental cavernous malformations 
is a complex issue. Cavernous malforma-
tions have variable courses. Some may 
remain relatively benign, but others may 
bleed and cause significant neurological 
deficit. Current guidelines suggest that 
asymptomatic CM patients should be 
followed with serial imaging studies and 
periodic clinical exams to continually 
assess whether or not intervention is 
warranted.12 
Additional research is needed to fully 
understand the utility of radiosurgery 
for treating cavernous malformations. 
Patients with high-risk or symptomatic 
cavernous malformations appear to 
benefit most from radiosurgery. The 
role of radiosurgery in treating inciden-
tally found cavernous malformations is 
less clear. A randomized controlled trial 
comparing radiosurgery to conservative 
management would be most beneficial.
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beyond two years.11 Evidence in support 
of radiosurgery for high risk symptomatic 
patients is compelling, yet there is not a 
significant body of evidence supporting 
radiosurgery for incidental CMs. 
The lack of randomized controlled 
studies, and a paucity of long term effects 
and safety data has limited the quality of 
evidence relating to radiosurgery, and so 
its indications and effectiveness are still 
debated.2 Consequently, although SRS 
may be beneficial for surgically inacces-
sible CMs with a high risk for rebleed, it 
is rarely used. Patients who do not have 
a history of more than one significant 
bleed should undergo conservative 
management rather than SRS because of 
the significant risk of post-SRS bleeding 
for up to two years.13 
Dose of radiation is also an important 
consideration when determining whether 
or not to use radiosurgery. In attempt to 
reduce the radiation-related sequelae 
in eloquent locations, some surgeons 
have reduced the dose of radiation used 
to treat cavernous malformations.11 A 
significant concern with the reduction 
in radiation dose is whether or not the 
radiosurgery is effective at a lower dose. 
Current imaging studies are unable to 
demonstrate whether or not radiosur-
gery is effective, and consequently all 
studies are based on clinical outcomes.12 
Many studies have examined the safest, 
and most effective mean tumor margin 
dose for proper obliteration of the CM 
and determined it to be between 12 and 
16 Gy.15 Lunsford et al. found that their 
mean marginal dose of 16 Gy resulted 
in adverse radiation effects in 11.65% of 
their radiosurgically treated patients, and 
Pollock et al. reported adverse radiation 
effects in 59% of patients with a mean 
marginal dose of 18 Gy.13,16 These studies 
highlight the significance of adverse 
effects that can occur with radiosurgery, 
and make the decision to treat a radio-
surgically eligible incidental cavernous 
malformation more difficult, especially 
taking into consideration the eloquent 
areas involved.
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